TL;DR
This study identifies specific circular RNAs (circRNAs) in peripheral blood cells that are differentially expressed in patients with active tuberculosis (TB). These circRNAs show promise as diagnostic biomarkers for TB, and one particular circRNA, hsa_circRNA_101128, appears to play a role in the disease's pathogenesis by interacting with microRNAs involved in immune response.
What Problem Does This Paper Address?
Tuberculosis (TB) remains a significant global health challenge, particularly in low- and middle-income countries. Early and accurate diagnosis is crucial for effective treatment and improved patient outcomes. However, current diagnostic methods often face limitations in specificity and sensitivity, and the underlying molecular mechanisms of TB are not fully understood. This lack of understanding hinders the development of novel diagnostic tools and therapeutic strategies. The paper aims to address this by investigating the potential of circular RNAs (circRNAs) as biomarkers for active TB and exploring their functional roles in the disease. CircRNAs are a relatively new class of non-coding RNAs that are stable and abundant, making them attractive candidates for diagnostic applications.
Methods
The researchers employed a multi-pronged approach:
- Microarray Analysis: This was the primary technique used to screen for differentially expressed circRNAs in peripheral blood mononuclear cells (PBMCs) from active TB patients compared to healthy controls.
- Reverse Transcription-Quantitative Polymerase Chain Reaction (RT-qPCR): This standard molecular biology technique was used to validate the findings from the microarray analysis, confirming the expression levels of specific circRNAs.
- Receiver Operating Characteristic (ROC) Curve Analysis: This statistical method was used to evaluate the diagnostic accuracy and predictive power of the identified circRNAs for distinguishing between TB patients and healthy individuals.
- Bioinformatics Analysis:
- miRNA Target Prediction: Software was used to predict potential microRNA (miRNA) response elements (MREs) within the dysregulated circRNAs, suggesting how they might interact with miRNAs.
- Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway Analysis: These analyses were performed to predict the biological functions and pathways that the identified circRNAs and their potential targets might be involved in.
Datasets
The study utilized peripheral blood mononuclear cells (PBMCs) collected from:
- 31 active TB patients (PTC group)
- 30 healthy controls (PCR group)
The microarray expression data has been submitted to the Gene Expression Omnibus (GEO) database under the accession number GSE117563.
Key Insights and Ideas
- CircRNAs as TB Biomarkers: The study strongly suggests that specific circRNAs in peripheral blood can serve as valuable biomarkers for diagnosing active TB. Their stability and differential expression in TB patients make them promising candidates.
- hsa_circRNA_101128's Regulatory Role: The research highlights a potential functional role for hsa_circRNA_101128. Its negative correlation with let-7a, a known regulator of immune response, suggests it may act as a "sponge" for this miRNA, influencing the host's response to Mycobacterium tuberculosis (Mtb) infection.
- Pathway Involvement: Bioinformatics analysis points to the involvement of hsa_circRNA_101128 in key signaling pathways like MAPK and PI3K-Akt, which are known to be relevant in TB pathogenesis. This provides a molecular basis for its potential role in the disease.
- Complexity of CircRNA Regulation: The findings underscore the intricate regulatory networks involving circRNAs and miRNAs in infectious diseases, opening avenues for further research into these interactions.
Key Results
- 171 Dysregulated CircRNAs: The microarray analysis identified a total of 171 circRNAs that were differentially expressed in PBMCs from active TB patients compared to healthy controls.
- Specific CircRNAs Identified: Four circRNAs were selected for validation: hsa_circRNA_059914, hsa_circRNA_103017, and hsa_circRNA_101128 were found to be increased in TB patients, while hsa_circRNA_062400 was decreased.
- Diagnostic Potential: ROC analysis demonstrated that hsa_circRNA_103017 (AUC: 0.870), hsa_circRNA_059914 (AUC: 0.821), and hsa_circRNA_101128 (AUC: 0.817) have significant diagnostic value for active TB.
- Correlation with let-7a: A negative correlation was observed between hsa_circRNA_101128 expression and let-7a levels in TB patients (r = -0.56, P < 0.05), suggesting a regulatory interaction.
Limitations and Future Work
- Sample Size: The study acknowledges that the findings are based on a relatively small sample size (31 TB patients), which may limit the generalizability of the results.
- Validation of Functional Roles: While bioinformatics analysis suggests potential functions and interactions, further experimental validation is needed to confirm the precise roles of these circRNAs in TB pathogenesis.
- Larger Cohort Studies: The authors emphasize the need for larger clinical cohort studies to validate the diagnostic potential of these circRNAs and to explore their functional implications more deeply.
- Mechanistic Studies: Future research should focus on elucidating the detailed molecular mechanisms by which these dysregulated circRNAs contribute to TB infection and progression, particularly the interplay between hsa_circRNA_101128 and its target miRNAs.
Summary updated